Cargando…

Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma

BACKGROUND: CD157/Bst1 glycoprotein is expressed in >85% of malignant pleural mesotheliomas and is a marker of enhanced tumor aggressiveness. RESULTS: In vitro, mesothelial cells (malignant and non-malignant) released CD157 in soluble form or as an exosomal protein. In vivo, sCD157 is released an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Augeri, Stefania, Capano, Stefania, Morone, Simona, Fissolo, Giulia, Giacomino, Alice, Peola, Silvia, Drace, Zahida, Rapa, Ida, Novello, Silvia, Volante, Marco, Righi, Luisella, Ferrero, Enza, Ortolan, Erika, Funaro, Ada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978265/ https://www.ncbi.nlm.nih.gov/pubmed/29854315 http://dx.doi.org/10.18632/oncotarget.25237

Ejemplares similares

CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome
por: Ortolan, Erika, et al.
Publicado: (2014)

CD157: From Myeloid Cell Differentiation Marker to Therapeutic Target in Acute Myeloid Leukemia
por: Yakymiv, Yuliya, et al.
Publicado: (2019)

CD157 signaling promotes survival of acute myeloid leukemia cells and modulates sensitivity to cytarabine through regulation of anti-apoptotic Mcl-1
por: Yakymiv, Yuliya, et al.
Publicado: (2021)

Human canonical CD157/Bst1 is an alternatively spliced isoform masking a previously unidentified primate-specific exon included in a novel transcript
por: Ferrero, Enza, et al.
Publicado: (2017)

Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition
por: Napoli, Francesca, et al.
Publicado: (2022)

Overexpression of CD157 Contributes to Epithelial Ovarian Cancer Progression by Promoting Mesenchymal Differentiation
por: Morone, Simona, et al.
Publicado: (2012)

Correction to: Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition
por: Napoli, Francesca, et al.
Publicado: (2022)

Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma
por: Napoli, Francesca, et al.
Publicado: (2021)

NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images
por: Liberini, Virginia, et al.
Publicado: (2021)

Detection and characterization of classical and “uncommon” exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing
por: Righi, Luisella, et al.
Publicado: (2013)

Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes
por: Mogavero, Andrea, et al.
Publicado: (2023)

Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma
por: Anobile, Dario P., et al.
Publicado: (2021)

Unprecedented long‐term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo‐ and immunotherapeutic regimens
por: Cerbone, Luigi, et al.
Publicado: (2023)

SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma
por: Salaroglio, Iris Chiara, et al.
Publicado: (2022)

Management of Pleural Effusion Secondary to Malignant Mesothelioma
por: Musso, Valeria, et al.
Publicado: (2021)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

A case of pleural mesothelioma with effusive-constrictive pericarditis.
por: Weir, N. A., et al.
Publicado: (2001)

MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
por: Birnie, Kimberly A., et al.
Publicado: (2019)

Hyaluronic acid in viscous malignant mesothelioma pleural effusion
por: Cheah, Hui Min, et al.
Publicado: (2020)

IκBα targeting promotes oxidative stress-dependent cell death
por: Carrà, Giovanna, et al.
Publicado: (2021)

Case report: Steroid responsive mesothelioma-related pleural effusion
por: Shehata, Mena, et al.
Publicado: (2018)

Profile of soluble factors in pleural effusions predict prognosis in mesothelioma
por: Dick, I.M., et al.
Publicado: (2022)

Recurrent Pericardial and Pleural Effusion due to Pericardial Pleomorphic Mesothelioma
por: Segura-Méndez, Bárbara, et al.
Publicado: (2022)

Multiple serous membrane effusion caused by primary pericardial mesothelioma
por: Dung, Bui The, et al.
Publicado: (2023)

Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma
por: Villanova, Tania, et al.
Publicado: (2019)

Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion
por: Tsuji, S, et al.
Publicado: (2010)

Parakeratotic-like cells in effusions — A clue to diagnosis of malignant mesothelioma
por: Gao, Ling, et al.
Publicado: (2012)

Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
por: Takeuchi, Eiji, et al.
Publicado: (2020)

Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma
por: Bria, Emilio, et al.
Publicado: (2015)

Diagnostic Accuracy of Calretinin for Malignant Mesothelioma in Serous Effusions: a Meta-analysis
por: Li, Diandian, et al.
Publicado: (2015)

CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells
por: Germano, Antonina, et al.
Publicado: (2018)

In vitro dexamethasone treatment does not induce alternative ATM transcripts in cells from Ataxia–Telangiectasia patients
por: Pozzi, Elisa, et al.
Publicado: (2020)

Association of Inherited Genotype and Severity of Clinical Presentation in Subjects with Verified Pas III Disorder
por: Beslic, Vanja Karlovic, et al.
Publicado: (2022)

Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations
por: Bironzo, Paolo, et al.
Publicado: (2021)

Immunohistochemistry with 3 different clones in anaplastic lymphoma kinase fluorescence in situ hybridization positive non-small-cell lung cancer with thymidylate synthase expression analysis: a multicentre, retrospective, Italian study
por: Bironzo, Paolo, et al.
Publicado: (2022)

Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions
por: Szulkin, Adam, et al.
Publicado: (2014)

Malignant pleural mesothelioma presenting with remitting–relapsing pleural effusions: report of two cases
por: Muruganandan, Sanjeevan, et al.
Publicado: (2018)

Unexplained Pleural Effusion Leads to the Revelation of a Malignant Mesothelioma: A Case Report
por: Rhazari, Meriem, et al.
Publicado: (2022)

Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids: A Proof of Concept
por: Pelosi, Giuseppe, et al.
Publicado: (2019)

Improving lung cancer outcomes through smoking cessation: the Women Against Lung Cancer in Europe (WALCE) experience
por: Capelletto, Enrica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3onglfmr9okeov9kt4d0v6fd33